跳至主要内容
临床试验/ACTRN12621000145808
ACTRN12621000145808进行中(未招募)未知

Implementing a Stepped Care Model to Address Fear of Cancer Recurrence in Early Stage (0-II) Melanoma Patients - A Pilot Study

Melanoma Centre for Research Excellence0 个研究点目标入组 115 人开始时间: 2021年2月12日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
115

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of stage 0, I or II melanoma.
  • Sufficient English and cognitive skills to independently read the Participant Information Sheet, Consent Form and study materials.
  • Able to give informed consent to participate in the study.
  • Sufficient hearing to participate in the psychotherapeutic telehealth sessions.

排除标准

  • Diagnosis of stage III or IV (metastatic) melanoma.
  • Patients with high risk of melanoma but have never received a diagnosis of the disease.
  • Diagnosis of severe depression, psychotic illness or other serious psychiatric condition.
  • Significant cognitive and / or hearing impairment that would prevent understanding of Participant Information Statement, study materials and participation in telehealth sessions.

研究者

发起方
Melanoma Centre for Research Excellence

相似试验